Selective amino acid deficiency in patients with impaired glucose tolerance and type 2 diabetes

[1]  Guoyao Wu,et al.  Amino acids: metabolism, functions, and nutrition , 2009, Amino Acids.

[2]  Mark Ellrichmann,et al.  Predictors of Incretin Concentrations in Subjects With Normal, Impaired, and Diabetic Glucose Tolerance , 2008, Diabetes.

[3]  M. Nauck,et al.  Incretins and the development of type 2 diabetes , 2006, Current diabetes reports.

[4]  Johannes D Veldhuis,et al.  Postprandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: further evidence for the intraislet insulin hypothesis. , 2006, Diabetes.

[5]  Y. Zhang,et al.  Gamma-aminobutyric acid up- and downregulates insulin secretion from beta cells in concert with changes in glucose concentration , 2006, Diabetologia.

[6]  A. M. Habib,et al.  The neurotransmitters glycine and GABA stimulate glucagon‐like peptide‐1 release from the GLUTag cell line , 2005, The Journal of physiology.

[7]  M. Nauck,et al.  Glucagon‐like peptide 1(GLP‐1) in biology and pathology , 2005, Diabetes/metabolism research and reviews.

[8]  S. Hazen,et al.  Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  G. Rutter,et al.  Glutamine potently stimulates glucagon-like peptide-1 secretion from GLUTag cells , 2004, Diabetologia.

[10]  M. Brosnan,et al.  Amino acid metabolism in the Zucker diabetic fatty rat: effects of insulin resistance and of type 2 diabetes. , 2004, Canadian journal of physiology and pharmacology.

[11]  P. Rorsman,et al.  Glucose inhibition of glucagon secretion from rat alpha-cells is mediated by GABA released from neighboring beta-cells. , 2004, Diabetes.

[12]  H. Kettenmann,et al.  Expression of functional GABAA receptors in neuroendocrine gastropancreatic cells , 1995, Pflügers Archiv.

[13]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[14]  K. Nair,et al.  Effect of poor diabetic control and obesity on whole body protein metabolism in man , 1983, Diabetologia.

[15]  Wim H M Saris,et al.  Amino acid ingestion strongly enhances insulin secretion in patients with long-term type 2 diabetes. , 2003, Diabetes care.

[16]  J. Holst,et al.  Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes. , 2001, Diabetes.

[17]  J. Holst,et al.  Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide. , 2000, The Journal of clinical endocrinology and metabolism.

[18]  B. Ahrén,et al.  Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine , 1998, Diabetologia.

[19]  W. Graier,et al.  Effects of low‐dose l‐arginine on insulin‐mediated vasodilatation and insulin sensitivity , 1997, European journal of clinical investigation.

[20]  E. Volpi,et al.  Contribution of Amino Acids and Insulin to Protein Anabolism During Meal Absorption , 1996, Diabetes.

[21]  K. Nair,et al.  Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients. , 1995, The Journal of clinical investigation.

[22]  J. Holst,et al.  Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. , 1995, The Journal of clinical endocrinology and metabolism.

[23]  P. Rorsman,et al.  Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels , 1989, Nature.

[24]  J. Holst.  Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin. , 1982, The Biochemical journal.

[25]  C. Invitti,et al.  Effects of gamma aminobutyric acid (GABA) and muscimol on endocrine pancreatic function in man. , 1982, Metabolism: clinical and experimental.

[26]  S. Raptis,et al.  Differences in insulin, growth hormone and pancreatic enzyme secretion after intravenous and intraduodenal administration of mixed amino acids in man. , 1973, The New England journal of medicine.

[27]  D. Steinberg,et al.  Stimulation of insulin secretion by infusion of free fatty acids. , 1969, The Journal of clinical investigation.